Position in NTLA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,031,652
+$345,810 QoQ
Shares Held
548,491
-26.2% QoQ
Ownership
0.393%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. NTLA ranks #87 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in NTLA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,031,652 | 548,491 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,685,842 | 743,698 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $7,608,675 | 440,572 | Shares | Other | 2025-11-26 | |
| 2025-06-30 | $8,821,727 | 940,483 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,865,171 | 543,625 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $6,512,317 | 558,518 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $13,338,056 | 649,054 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $14,974,564 | 669,105 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $14,940,871 | 543,107 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $19,395,203 | 636,117 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $19,446,801 | 615,016 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $26,643,608 | 653,350 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $25,013,086 | 671,132 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $23,118,703 | 662,617 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $35,861,795 | 640,847 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $33,253,933 | 642,464 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $45,634,506 | 627,969 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $79,027,710 | 668,367 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $66,233,474 | 493,727 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $145,164,779 | 896,577 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $72,384,711 | 901,934 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $33,609,624 | 617,824 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $8,512,536 | 428,196 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,522,105 | 310,281 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $2,734,896 | 223,622 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||